The prevalence of unrecognized adult celiac disease in Central Anatolia

Journal of Clinical Gastroenterology

Volumn 39, Issue 6, 2005, Pages 508-511

  Gursoy, Sebnem ^a   Guven, Kadri ^a   Simsek, Tayfun ^a   Yurci, Alper ^a   Torun, Edip ^a   Koc, Nedret ^a   Patiroglu, Tahir E ^a   Ozbakir, Omer ^a   Yucesoy, Mehmet ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Anti tissue transaminase; Celiac disease; Prevalence

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CELIAC DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PREVALENCE; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ADULT; BIOPSY; CELIAC DISEASE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; PREVALENCE; STATISTICS, NONPARAMETRIC; TURKEY;

EID: 20844445472     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000165664.87153.e1     Document Type: Article

References (52)

1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology, 2001;120:636-651.
2. Trier JS. Celiac sprue and refractory sprue. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 6th ed. Philadelphia: Saunders, 1998:1557-1573.
3. Ciclitira PJ. AGA technical review on celiac sprue. Gastroenterology. 2001;120:1526-1540.
4. Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterology. 1998;115:206-210.
5. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 2000;119:234-242.
6. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology. 1993;105:910-922.
7. Bottaro G, Cataldo F, Rotolo N, et al. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases. Am J Gastroenterol. 1999;94:691-696.
8. Feighery C. Fortnightly review: coeliac disease. BMJ. 1999;319:236-239.
9. Hankey GL, Holmes GKT. Coeliac disease in the elderly. Gut. 1994;35: 65-67.
10. Kennedy NP, Feighery C. Clinical features of celiac disease today. Biomed Pharmacother. 2000;54:373-380.
11. Farrell RJ, Kelly CP. Current concepts celiac sprue. N Engl J Med. 2002; 346:180-188.
12. Ferguson A, Arranz E, Mahony SO. Clinical and pathological spectrum of coeliac disease: active, silent, latent, potential. Gut. 1993;34:150-151.
13. Troncone R, Greco L, Mayer M, et al. Latent and potential coeliac disease. Acta Paediatr Suppl. 1996;412:10-14.
14. Nehra V. New clinical issues in celiac disease. Gastroenterol Clin North Am. 1998;27:453-465.
15. Holmes GKT. Non-malignant complications of coeliac disease. Acta Paediatr Suppl. 1996;412:68-75.
16. Holmes GKT, Prior P, Lane MR, et al. Malignancy in coeliac disease-effect of gluten free diet. Gut. 1989;30:333-338.
17. Logan RF, Rifkind EA, Turner ID, et al. Mortality in coeliac disease. Gastroenterology. 1989;97:265-271.
18. Trier JS. Diagnosis of celiac sprue. Gastroenterology. 1998;115:211-216.
19. Pruessner HT. Detecting celiac disease in your patients. Am Fam Physician. 1998;57:1023-1034.
20. Murray JA. The widening spectrum of celiac disease. Am J Clin Nutr. 1999;69:354-365.
21. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med. 2003;348:2517-2524.
22. Fasano A, Berti I, Geraduzzi T, et al. Prevalence of celiac disease in at-risk groups in the United States. Arch Intern Med. 2003;163:286-292.
23. West J, Logan RF, Hill PG, et al. Sroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut. 2003;52:960-965.
24. Sacchetti L, Ferrajolo A, Salerno G, et al. Diagnostic value of various serum antibodies detected by diverse methods in childhood celiac disease. Clin Chem. 1996;42:1838-42.
25. Vogelsang H, Genser D, Wyatt J, et al. Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol. 1995;90:394-398.
26. Grodzinsky E, Hed J, Skogh T. IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy. 1994;49:593-597.
27. Corrao G, Corazza GR, Andreani ML, et al. Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut. 1994;35:771-775.
28. Sulkanen S, Halttunen T, Launla K, et al. Tissue transglutaminase auto-antibody enzyme-linked immunosorbent assay in detecting coeliac disease. Gastroenterology. 1998;115:1322-1328.
29. Chan AW, Butzner D, McKenna R, et al. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics. 2001;107:e8.
30. Dieterich W, Laag E, Schöpper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 1998; 115:1327-1331.
31. Marsh MN. Gluten, major histocompatibility complex, and the intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('Celiac Sprue'). Gastroenterology. 1992;102:330-354.
32. Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother. 2000;54:368-372.
33. Oztürk S, Serinöz E, Keklik T, et al. Histopathological assesment in cases with gluten-sensitive enteropathy: significance of typing. Turk J Gastroenterol 2000;11:150-154.
34. Tümer L, Hasanoǧlu A, Aybay C. Endomysium antibodies in the diagnosis of celiac disease in short-statured children with no gastrointestinal symptoms. Pediatr Int. 2001;43:71-73.
35. Altuntaş B, Kansu A, Ensari A, et al. Celiac disease in Turkish short-statured children and the value of antigliadin antibody in diagnosis [Abstract]. Acta Paediatr Jpn. 1998;40:457-460.
36. Tatar G, Elsürer R, Balaban YH, et al. The prevalence of Celiac disease on blood donors using the anti-TTG test. Turk J Gastroenterol. 2002;13 (suppl 1):33.
37. Yildirim N, Göral V, Kaplan A. The antigliadin and endomysium antibodies prevalence in primary school patients between 7-14 years old. Turk J Gastroenterol. 2002;13(suppl 1):145.
38. Kolho KL, Farkkila MA, Savilahti E. Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol. 1998;33:1280-1283.
39. Catassi C, Ratsch IM, Fabiani E, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994;343:200-203.
40. Catassi C, Fabiani E, Ratsch IM, et al. The coeliac iceberg in Italy: a multicentre antigliadin antibodies screening for coeliac disease in school-age subjects. Acta Paediatr Suppl. 1996;412:29-35.
41. Sanders DS, Carter MJ, Hurlstone DP, et al. Associaton of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 2001;358: 1504-1508.
42. Branski D, Troncone R. Celiac disease: a reappraisal. J Pediatr. 1998;133: 181-187.
43. Maki M, Collin P. Coeliac disease. Lancet. 1997;349:1755-1759.
44. Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol. 1997;32:1129-1133.
45. Ivarsson A, Persson LA, Juto P, et al. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 1999;245:63-68.
46. Rostami K, Mulder CJJ, Werre JM, et al. High prevalence of celiac disease in appearently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in Dutch population. Scand J Gastroenterol. 1999;34:276-279.
47. Cassandra GDS, Csizmadia J, Mearin ML, et al. An iceberg of childhood coeliac disease in the Netherlands. Lancet. 1999;353:813-814.
48. Johnston SD, Watson RGP, McMillan SA, et al. Prevalence of coeliac disease in Northern Ireland. Lancet. 1997;350:1370.
49. Korponay-Szabo IR, Kovacs JB, Czinner A, et al. High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies. J Pediatr Gastroenterol Nutr. 1999;28:26-30.
50. Talley NJ, Valdovinos M, Petterson TM, et al. Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol. 1994;89:843-846.
51. Hill I, Fasano A, Schwartz R, et al. The prevalence of celiac disease in at risk groups of children in the United States. J Pediatr. 2000;136: 86-90.
52. Not T, Horvath K, Hill D, et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibadies in healthy blood donors. Scand J Gastroenterol. 1998;33:494-498.